公司新闻(英文)
January 17, 2018 / 9:32 PM / a year ago

BRIEF-Amgen says Analysis From Kyprolis Trial Published in Journal Of Clinical Oncology

1 分钟阅读

Jan 17 (Reuters) - Amgen Inc:

* OVERALL SURVIVAL ANALYSIS FROM KYPROLIS® (CARFILZOMIB) PHASE 3 ASPIRE TRIAL PUBLISHED IN THE JOURNAL OF CLINICAL ONCOLOGY Source text for Eikon: Further company coverage:

我们的标准：汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below